Taking Action in Early AD: A Primary Care Guide to Identifying Appropriate Patients

Overview

Medication is available that targets underlying pathology and may slow progression in early Alzheimer’s disease (AD), but appropriate patient selection is critical. This presentation, developed specifically for primary care practitioners, highlights the importance of early identification of mild cognitive impairment (MCI) due to AD and reviews tools that can be integrated into clinical practice to help screen patients. Attendees will learn about the characteristics of patients presenting with MCI so they can be referred to neurology for disease confirmation and treatment. In addition, attendees will learn about the mechanism of action and clinical efficacy and safety profile of an anti-amyloid therapy approved for the treatment of patients with MCI or mild dementia due to AD.